Clinical trials
Withdrawn Melanoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 7 |
| National Cancer Institute (NCI) | 7 |
| M.D. Anderson Cancer Center | 6 |
| Dana-Farber Cancer Institute | 3 |
| University of Pittsburgh | 3 |
| Case Comprehensive Cancer Center | 2 |
| Duke University | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 110 |
| Neoplasm Metastasis | 12 |
| Breast Neoplasms | 8 |
| Carcinoma, Renal Cell | 7 |
| Lung Neoplasms | 7 |
| Sarcoma | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Skin Neoplasms | 6 |
| Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
Trials
Showing 76 to 100 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.